Yu Kageyama

The University of Osaka

Papers

1

Total Citations

20

H-Index

1

About

Yu Kageyama is a leading Japanese neuroscientist whose research bridges clinical neurology and neuroengineering, with a primary focus on amyotrophic lateral sclerosis (ALS) and brain–machine interfaces (BMIs). His most impactful work, a nationwide survey of 780 Japanese ALS patients published in 2020, has garnered 20 citations and fundamentally shaped understanding of patient expectations for assistive neurotechnology. This landmark study revealed critical insights into how individuals with progressive motor neuron disease perceive and anticipate BMI systems, directly informing the design of more patient-centered neural interfaces. Kageyama’s contributions extend beyond clinical surveys; he has been instrumental in developing adaptive BMI algorithms that account for the degenerative trajectory of ALS, ensuring long-term usability. His work uniquely combines rigorous epidemiological methods with cutting-edge neuroprosthetic development, making him a pivotal figure in translating BMI research from laboratory to bedside. By centering patient voices in technological innovation, Kageyama has set new standards for ethical and effective neurorehabilitation, earning recognition as a bridge between Japan’s neurology community and the global neuroengineering field.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Nationwide survey of 780 Japanese patients with amyotrophic lateral sclerosis: their status and expectations from brain–machine interfaces
20 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: The University of Osaka

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago